Recent Insights Into Mechanisms and Clinical Approaches to Electrical Storm

Area of Science:

• Cardiology
• Electrophysiology
• Critical Care Medicine

Background:

• Electrical storm, defined as recurrent ventricular tachycardia/fibrillation, is increasingly prevalent with implantable cardioverter defibrillator (ICD) use.
• This condition often affects patients with structural heart disease or inherited channelopathies and is a medical emergency impacting prognosis.
• Sympathetic nervous system activation plays a crucial role in the initiation and perpetuation of electrical storm.

Purpose of the Study:

• To review the pathophysiologic mechanisms, clinical features, prognosis, and therapeutic strategies for electrical storm.
• To outline a clinical approach to managing this complex condition based on its underlying mechanisms.

Main Methods:

• Review of existing literature on electrical storm, encompassing pathophysiology, clinical presentation, and treatment modalities.
• Analysis of management strategies including ICD interrogation/reprogramming, trigger identification, autonomic modulation, and antiarrhythmic therapies.
• Exploration of novel therapeutic options targeting the arrhythmogenic substrate.

Main Results:

• Management requires addressing hemodynamic status, reducing ICD shocks, identifying/managing triggers (e.g., ischemia, electrolyte imbalance), and employing antiarrhythmic drugs or ablation.
• Autonomic modulation via beta-blockers, sedation, or sympathetic denervation is a cornerstone of treatment.
• Targeting the ventricular arrhythmia substrate with medications, catheter ablation, or stereotactic radiation therapy offers definitive management.

Conclusions:

• Electrical storm is a complex medical emergency necessitating a multi-faceted management approach.
• Understanding the central role of sympathetic activation and arrhythmogenic substrate is vital for effective therapeutic strategies.
• Integrated management focusing on autonomic balance and arrhythmia substrate modification improves patient outcomes.